Pablo Ferraro, MD, discusses the use of molecular profiling in pancreatic cancer.
Pablo Ferraro, MD
Advertisement
Articles by Pablo Ferraro, MD
Advertisement
Latest Updated Articles
Dr. Ferraro on the Use of Molecular Profiling in Pancreatic CancerPublished: January 17th 2020 | Updated:
Advertisement
Advertisement
Trending on OncLive
1
FDA Accepts BLA for Ivonescimab Plus Chemotherapy in EGFR-Mutant NSCLC After TKI Progression
2
FDA Approval Sought for Lirafugratinib in Second-Line, FGFR2-Altered Cholangiocarcinoma
3
Aligning Patient Goals and Toxicity Burden Are Key in First-Line Chemo Selection in Pancreatic Cancer
4
Dr Spencer on First-Line Chemo Selection in Metastatic Pancreatic Adenocarcinoma
5